Skip to main navigation

About
Technology
Clinical Trials
- Pipeline
- Nant Cancer Vaccine
News
Investors
Investor Relations
Careers
- Join Our Kwest
- We’re Hiring
Contact
Patients

Select Page

About
Technology
Clinical Trials
- Pipeline
- Nant Cancer Vaccine
News
Investors
Investor Relations
Careers
- Join Our Kwest
- We’re Hiring
Contact
Patients

INVESTOR RELATIONS

Contact US

To request information, please submit the form below:
Personal Information Required fields denoted by an asterisk (*).

Name

Email

Subject

Comments

© 2018 NantKwest. All Rights Reserved. A member of the NantWorks ecosystem of companies

Privacy Policy | Legal Notice | Patent Notice

‘Nantkwest’, ‘aNK’, 'haNK', 'taNK', ‘vaNK’, 't-haNK', 'NK-92', ‘Neukosome’, 'Living Drugs in a Bag', and ‘Nature’s First Responder’ are trademarks or registered trademarks of Nantkwest, Inc.

The Natural Killer Cell platform consists of investigational agents that are restricted by federal law to investigational use only.
The Natural Killer Cell platform is being investigated in multiple clinical trials across tumor sites.

The content of this website is protected by Title 17 of the U.S. Code and may not be reproduced in whole or in part by any means.